Duloxetine Hydrochloride is a drug owned by Almatica Pharma Llc. It is protected by 1 US drug patent filed in 2026 out of which none have expired yet. Based on its patents and exclusivities, its generic launch date is estimated to be Jan 13, 2046. Details of Duloxetine Hydrochloride's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US12721817 | NA |
Jan, 2046
(19 years from now) | Active |
US patents provide insights into the exclusivity only within the United States, but
Duloxetine Hydrochloride is protected by patents in multiple countries.
Understanding
the full scope
of patent protection is crucial in strategizing market entry. By looking at the broader patent
landscape, you can
identify markets with weaker patent protection which could be ideal generic entry points. The
following section offers
details on Duloxetine Hydrochloride's family patents as well as insights into
ongoing legal events
on those patents.
Duloxetine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Duloxetine Hydrochloride's generic launch date based on the expiry of its last outstanding patent is estimated to be Jan 13, 2046 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Duloxetine Hydrochloride Generic API suppliers:
Duloxetine Hydrochloride is the generic name for the brand Duloxetine Hydrochloride. 23 different companies have already filed for the generic of Duloxetine Hydrochloride, with Ajanta Pharma Ltd having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Duloxetine Hydrochloride's generic
Alternative Brands for Duloxetine Hydrochloride
There are several other brand drugs using the same active ingredient (Duloxetine Hydrochloride) as Duloxetine Hydrochloride. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| Lilly |
| |
| Sun Pharm |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Duloxetine Hydrochloride, Duloxetine Hydrochloride's active ingredient. Check the complete list of approved generic manufacturers for Duloxetine Hydrochloride
About Duloxetine Hydrochloride
Duloxetine Hydrochloride is a drug owned by Almatica Pharma Llc. Duloxetine Hydrochloride uses Duloxetine Hydrochloride as an active ingredient. Duloxetine Hydrochloride was launched by Almatica in 2026.
Approval Date:
Duloxetine Hydrochloride was approved by FDA for market use on 27 February, 2026.
Active Ingredient:
Duloxetine Hydrochloride uses Duloxetine Hydrochloride as the active ingredient. Check out other Drugs and Companies using Duloxetine Hydrochloride ingredient
Dosage:
Duloxetine Hydrochloride is available in capsule, delayed rel pellets form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| EQ 80MG BASE | CAPSULE, DELAYED REL PELLETS | Prescription | ORAL |
| EQ 90MG BASE | CAPSULE, DELAYED REL PELLETS | Prescription | ORAL |
| EQ 120MG BASE | CAPSULE, DELAYED REL PELLETS | Prescription | ORAL |